- Home
- BRLT vs MDCX Comparison
BRLT vs MDCX Comparison
Compare BRLT & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BRLT | MDCX |
|---|---|---|
| Founded | 2005 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Specialties | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.6M | 31.1M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | BRLT | MDCX |
|---|---|---|
| Price | $1.56 | $1.19 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $1.80 | ★ $23.50 |
| AVG Volume (30 Days) | 69.1K | ★ 270.4K |
| Earning Date | 03-11-2026 | 02-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $432,597,000.00 | N/A |
| Revenue This Year | $5.92 | N/A |
| Revenue Next Year | $4.06 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 1.31 | N/A |
| 52 Week Low | $1.25 | $1.14 |
| 52 Week High | $3.10 | $8.94 |
Technical Indicators
Market Signals| Indicator | BRLT | MDCX |
|---|---|---|
| Relative Strength Index (RSI) | 37.38 | 29.19 |
| Support Level | $1.53 | $1.14 |
| Resistance Level | $1.66 | $1.29 |
| Average True Range (ATR) | 0.08 | 0.12 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 11.11 | 11.43 |
Price Performance
Historical ComparisonAbout BRLT Brilliant Earth Group Inc.
Brilliant Earth Group Inc is a digitally native omnichannel jewelry company. The company designs, procures and sells ethically-sourced diamonds, gemstones and jewelry online and through showrooms. The sales of the company consist of revenue from diamond, gemstone, and jewelry retail sales. The company sells its products in the U.S. and other international countries, of which a majority of revenue is derived from the U.S.
About MDCX Medicus Pharma Ltd.
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.